Treatment Information

Back

Ovarian Cancer treatment details. Radiation.

University of Heidelberg, Heidelberg, Germany.

Survival: monthsCountry:Germany
Toxiciy Grade:3City/State/Province:Heidelberg
Treatments:RadiationHospital:University of Heidelberg
Drugs:Journal:Link
Date:Mar 2015

Description:

Patients:
This phase 2 study involved 16 ovarian cancer patients who had received prior carboplatin/taxane chemotherapy. The median patient age was 57 years.

Treatment:
Patients received whole-abdominal irradiation (radiation therapy).

Toxicities:
The most severe toxicities were of grade 3 and included diarrhea and leukopenia. Grade 2 nausea/vomiting was also reported.

Results:
The median overall survival was 42.1 months.

Correspondence: Dr. Katja Lindel; email: katja.lindel@med.uni-heidelberg.de



Back